Context : Asymptomatic sexually transmitted infections (STIs), such as hepatitis B and syphilis, affect more than one million people aged 15 to 49 every day. A better understanding of their prevalence is essential in order to move towards their elimination and contribute to a 90% reduction in chronic hepatitis cases by 2030. Objective : To analyze changes in the epidemiological trends of hepatitis B and syphilis between 2013 and 2024 in order to strengthen control strategies and improve medical care for patients. Me thod : A descriptive cross-sectional study was conducted, including retrospective data collection from the CERBA database (2013-2023) and prospective data collection in 2024. Biological samples were analyzed using rapid diagnostic tests: Determine TM HBsAg 2 and Determine TM Syphilis TP. Results : From 2013 to 2024, among the 2,604 participants (mean age: 30.33 ± 10.87 years), the prevalence of hepatitis B virus (HBV) was 8.49% and that of syphilis was 1.61%. A downward trend in HBV was observed during the study period: 8.91% in 2013, 8.45% in 2016, 8.75% in 2020, and 7.83% in 2024. For syphilis, the rates were 2.30% in 2016, 2.61% in 2020 and 1.54% in 2024. Over the same period, HBV prevalence was higher in men than in women (9.24% vs. 7.10%, P = 0.061) and syphilis prevalence was also higher in men (1.72% vs. 1.42%, P = 0.563). In the management of HBV, tenofovir disoproxil fumarate (TDF) remains the reference molecule, prescribed in 98.1% of cases, while tenofovir alafenamide (TAF) is used marginally (1.9%), and the hepatitis B vaccine (HepB) remains accessible. Conclusion : The still high prevalence of HBV in Burkina Faso requires increased vaccination efforts, particularly among at-risk groups, as well as equitable access to antivirals, with the goal of reducing chronic forms of hepatitis B by 90% within a decade. Furthermore, the decline in the prevalence of syphilis highlights the importance of early and continuous screening, treatment of partners and the implementation of effective prevention programs.
KeywordsHepatitis BSyphilisPrevalenceHepatitis B VaccineTenofovirAntibiotic
Quevauvilliers, J., Warnesson, E., Fingerhut, A., Somogyi, A. and Letonturier, P. (2016) Dictionnaire médical avec atlas anatomique, 6ème edition. Elsevier Masson. https://www.soignants.org/bibliotheque/livres/dictionnaire-medical-avec-atlas-anatomique-6eme-edition
WHO (2025) Syphilis. https://www.who.int/fr/news-room/fact-sheets/detail/syphilis
WHO (2025) Hepatitis B. https://www.who.int/fr/news-room/fact-sheets/detail/hepatitis-b
World Health Organisation (2024) Global Hepatitis Report 2024: Action for Access in Low-and Middle-Income Countries.
WHO (2024) WHO Sounds Alarm on Viral Hepatitis Infections Claiming 3,500 Lives Each Day. https://www.who.int/news/item/09-04-2024-who-sounds-alarm-on-viral-hepatitis-infections-claiming-3500-lives-each-day
World Health Organization (2023) Global Guidelines on Validation Elimination of Mother-to-Child Transmission of HIV, Syphilis and Hepatitis B Virus.
Schweitzer, A., Horn, J., Mikolajczyk, R.T., Krause, G. and Ott, J.J. (2015) Estimations of Worldwide Prevalence of Chronic Hepatitis B Virus Infection: A Systematic Review of Data Published between 1965 and 2013. The Lancet , 386, 1546-1555. https://doi.org/10.1016/s0140-6736(15)61412-x
Simpore, J., Granato, M., Santarelli, R., Nsme, R.A., Coluzzi, M., Pietra, V., et al . (2004) Prevalence of Infection by HHV-8, HIV, HCV and HBV among Pregnant Women in Burkina Faso. Journal of Clinical Virology , 31, 78-80. https://doi.org/10.1016/j.jcv.2004.06.001
Yelemkoure, E.T., Yonli, A.T., Montesano, C., Ouattara, A.K., Diarra, B., Zohoncon, T.M., et al . (2018) Prevention of Mother-To-Child Transmission of Hepatitis B Virus in Burkina Faso: Screening, Vaccination and Evaluation of Post-Vaccination Antibodies against Hepatitis B Surface Antigen in Newborns. Journal of Public Health in Africa , 9, a947. https://doi.org/10.4081/jphia.2018.816
Simpore, J., Savadogo, A., Ilboudo, D., Nadambega, M.C., Esposito, M., Yara, J., et al . (2006) Toxoplasma Gondii, HCV, and HBV Seroprevalence and Co-Infection among HIV-Positive and-Negative Pregnant Women in Burkina Faso. Journal of Medical Virology , 78, 730-733. https://doi.org/10.1002/jmv.20615
Wongjarupong, N., Oli, S., Sanou, M., Djigma, F., Kiba Koumare, A., Yonli, A.T., et al . (2021) Distribution and Incidence of Blood-Borne Infection among Blood Donors from Regional Transfusion Centers in Burkina Faso: A Comprehensive Study. The American Journal of Tropical Medicine and Hygiene , 104, 1577-1581. https://doi.org/10.4269/ajtmh.20-0601
Yooda, A.P., Sawadogo, S., Soubeiga, S.T., Obiri-Yeboah, D., Nebie, K., Ouattara, A.K., et al . (2019) Residual Risk of HIV, HCV, and HBV Transmission by Blood Transfusion between 2015 and 2017 at the Regional Blood Transfusion Center of Ouagadougou, Burkina Faso. Journal of Blood Medicine , 10, 53-58. https://doi.org/10.2147/jbm.s189079
Diarra, B., Ouattara, A.K., Wendkuuni Djigma, F., Rebeca Compaore, T., Obiri-Yeboah, D., Traore, L., et al . (2017) World Hepatitis Day in Burkina Faso, 2016: Awareness, Screening, Identification of HBV Markers, HBV/HCV Coinfection, and Vaccination. Hepatitis Monthly , 17, e13789. https://doi.org/10.5812/hepatmon.13789
Assih, M., Feteke, L., Bisseye, C., Ouermi, D., Djigma, F., Karou, S.D., et al . (2016) Molecular Diagnosis of the Human Immunodeficiency, Hepatitis B and C Viruses among Blood Donors in Lomé (Togo) by Multiplex Real Time PCR. Pan African Medical Journal , 25, Article 242. https://doi.org/10.11604/pamj.2016.25.242.7096
Traore, L., Triande, M.N., Zongo, S.V., Ouattara, A.K., Savadogo, M., Nignan, N., et al . (2025) Association between Extracellular Matrix Protein 1 (ECM1) Gene Polymorphisms (rs3834087 and Rs3754217) and Hepatitis B Virus Evolution in an African Cohort. Cellular and Molecular Biology , 70, 36-44. https://doi.org/10.14715/cmb/2024.70.12.5
(2017) Strategic Plan for the Fight Against Viral Hepatitis 2017-2021. https://insp.bf/wp-content/uploads/2023/06/Plan_strategique_h%C3%A9patites-virales-2017_2021-BF.pdf
Bisseye, C., Sanou, M., Nagalo, B.M., Kiba, A., Compaoré, T.R., Tao, I., et al . (2013) Epidemiology of Syphilis in Regional Blood Transfusion Centres in Burkina Faso, West Africa. Pan African Medical Journal , 16, Article 69. https://doi.org/10.11604/pamj.2013.16.69.2767
Nagalo, M.B. (2011) Seroprevalence of Human Immunodeficiency Virus, Hepatitis B and C Viruses and Syphilis among Blood Donors in Koudougou (Burkina Faso) in 2009. Blood Transfusion , 9, 419-424. https://doi.org/10.2450/2011.0112-10
World Health Organization (2023) WHO Prequalification of In Vitro Diagnostics: Public Report. https://extranet.who.int/prequal/sites/default/files/whopr_files/PQDx_0451-013-00_Determne_v3.pdf
World Health Organization (2022) WHO Prequalification of In Vitro Diagnostics: Public Report. Determine Syphilis TP. https://extranet.who.int/prequal/sites/default/files/whopr_files/PQDx_0485-013-00_DetermineSyphilisTPP_v1.0.pdf
Meda, N., Tuaillon, E., Kania, D., Tiendrebeogo, A., Pisoni, A., Zida, S., et al . (2018) Hepatitis B and C Virus Seroprevalence, Burkina Faso: A Cross-Sectional Study. Bulletin of the World Health Organization , 96, 750-759. https://doi.org/10.2471/blt.18.208603
Zouré, A.A., Nadembega, C., Ouermi, D., Ouattara, A.K., Traoré, L., Tiemtoré, A., et al . (2024) State of the HIV, Hepatitis B and C Virus Pandemic from 2003 to 2022 in Burkina Faso: Evolution of Prevalence Trends and Strategic Recommendations to Achieve the Who’s Goal for Their Eradication by 2030. Advances in Infectious Diseases , 14, 628-643. https://doi.org/10.4236/aid.2024.143046
Tripathi, N. and Mousa, O.Y. (2025) Hepatitis B. StatPearls.
Diarra, B., Yonli, A.T., Ouattara, A.K., Zohoncon, T.M., Traore, L., Nadembega, C., et al . (2018) World Hepatitis Day in Burkina Faso, 2017: Seroprevalence and Vaccination against Hepatitis B Virus to Achieve the 2030 Elimination Goal. Virology Journal , 15, Article No. 121. https://doi.org/10.1186/s12985-018-1032-5
Kiswendsida Yanogo, P., Sanou, E.N. and Meda, N. (2023) Facteurs associés au portage de l’AgHBs chez les personnes dépistées en milieu communautaire à Ouagadougou au Burkina en juillet 2018. Revue d ’ Épidémiologie et de Santé Publique , 71, Article ID: 101542. https://doi.org/10.1016/j.respe.2023.101542
Jary, A., Dienta, S., Leducq, V., Le Hingrat, Q., Cisse, M., Diarra, A.B., et al . (2019) Seroprevalence and Risk Factors for HIV, HCV, HBV and Syphilis among Blood Donors in Mali. BMC Infectious Diseases , 19, Article No. 1064. https://doi.org/10.1186/s12879-019-4699-3
Lingani, M., Akita, T., Ouoba, S., Sanou, A.M., Sugiyama, A., Tarnagda, Z., et al . (2018) High Prevalence of Hepatitis B Infections in Burkina Faso (1996-2017): A Systematic Review with Meta-Analysis of Epidemiological Studies. BMC Public Health , 18, Article No. 551. https://doi.org/10.1186/s12889-018-5432-7
Ouedraogo, H.G., Nikiema, A., Cissé, K., Ky-Zerbo, O., Samadoulougou, B., Ouedraogo, A., et al . (2019) Portage du virus de l’hépatite B chez les travailleuses du sexe dans trois villes secondaires du Burkina Faso: Koudougou, Ouahigouya et Tenkodogo. Revue Malienne d ’ Infectiologie et de Microbiologie , 14, 32-42. https://doi.org/10.53597/remim.v14i2.1368
Ouedraogo, H.G., Kouanda, S., Grosso, A., Compaoré, R., Camara, M., Dabire, C., et al . (2018) Hepatitis B, C, and D Virus and Human T-Cell Leukemia Virus Types 1 and 2 Infections and Correlates among Men Who Have Sex with Men in Ouagadougou, Burkina Faso. Virology Journal , 15, Article No. 194. https://doi.org/10.1186/s12985-018-1110-8
Newman, L., Rowley, J., Vander Hoorn, S., Wijesooriya, N.S., Unemo, M., Low, N., et al . (2015) Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting. PLOS ONE , 10, e0143304. https://doi.org/10.1371/journal.pone.0143304
Rowley, J., Vander Hoorn, S., Korenromp, E., Low, N., Unemo, M., Abu-Raddad, L.J., et al . (2019) Chlamydia, Gonorrhoea, Trichomoniasis and Syphilis: Global Prevalence and Incidence Estimates, 2016. Bulletin of the World Health Organization , 97, 548-562P. https://doi.org/10.2471/blt.18.228486
Kirakoya-Samadoulougou, F., Defer, M.-., Yaro, S., Fao, P., Ilboudo, F., Langani, Y., et al . (2010) Low Seroprevalence of Syphilis in Burkina Faso. Sexually Transmitted Infections , 87, 35-37. https://doi.org/10.1136/sti.2010.042465
Akakpo, A.S., Larabou, A., Saka, B., Téclessou, J.N., Singo, A., Dagnra, A., et al . (2022) Trends in HIV and Syphilis Prevalence among Pregnant Women Attending Antenatal Clinics in Togo: Analysis of Sentinel Serosurveillance. Médecine Tropicale et Santé Internationale , 2.
Boaitey, Y.A., Owusu-Ofori, A., Anyogu, A., Aghakhanian, F., Arora, N., Parr, J.B., et al . (2024) Prevalence of Yaws and Syphilis in the Ashanti Region of Ghana and Occurrence of H. Ducreyi, Herpes Simplex Virus 1 and Herpes Simplex Virus 2 in Skin Lesions Associated with Treponematoses. PLOS ONE , 19, e0295088. https://doi.org/10.1371/journal.pone.0295088
Geneva: World Health Organisation (2022) Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022-2030.
European Association for the Study of the Liver (2012) EASL Clinical Practice Guidelines: Management of Chronic Hepatitis B Virus Infection. Journal of Hepatology , 57, 167-185. https://doi.org/10.1016/j.jhep.2012.02.010
Ministry of Health (2019) Standards and Protocols for the Management of Viral Hepatitis in Burkina Faso.